Uther
Ipamorelin
Finnrick tested 3 samples of Ipamorelin (GHS agonist) from Uther between 9 Oct 2025 and 4 Nov 2025. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Ipamorelin tests from top-rated vendors:
All Ipamorelin tests from Uther
Samples are tested in commercial labs
Tests Count
Scores
Last
First
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Nov 2025 | View | 10mg | 11.500mg | +15.0% | 98.65% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 9 Oct 2025 | View | 10mg | 11.300mg | +13.0% | 99.79% | IP100727 | White Label / Gold Crimp / Clear Red Cap | Lab E | Vendor | |
| 9 Oct 2025 | View | 10mg | 10.900mg | +9.0% | 99.82% | IP100727 | White Label / Gold Crimp / Clear Red Cap | Lab E | Vendor | |
Launch with Finnrick
Some of the samples listed on this page were submitted by their vendor, as part of the Launch with Finnrick vendor support program.
The program is designed to help vendors get listed on the Finnrick web site while protecting the integrity of our rating system.
The vendor submitted four samples per product, two of which were tested by Finnrick for identity, purity and quantity according to our usual process. The vials were anonymized before being sent to the testing lab.